Hampton Falls, NH, United States of America

Basil Pawlyk

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Massachusetts Eye and Ear Infirmary, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Ucl Business Plc. Active years: 2019-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Basil Pawlyk

Introduction

Basil Pawlyk is a notable inventor based in Hampton Falls, NH (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of retinitis pigmentosa. With a total of 2 patents, his work has the potential to impact many lives suffering from this condition.

Latest Patents

Pawlyk's latest patents focus on RPGR gene therapy for retinitis pigmentosa. The methods he developed are aimed at treating human subjects who have X-linked Retinitis Pigmentosa (XLRP) or other clinically-defined ophthalmological conditions. These methods involve administering a nucleic acid that comprises an adeno-associated viral vector containing an abbreviated human RPGR cDNA. This innovative approach represents a significant advancement in the treatment of genetic eye disorders.

Career Highlights

Throughout his career, Basil Pawlyk has worked with esteemed organizations such as the Massachusetts Eye and Ear Infirmary and the United States of America, as represented by the Secretary, Department of Health and Human Services. His experience in these institutions has allowed him to refine his expertise in ophthalmological research and gene therapy.

Collaborations

Pawlyk has collaborated with notable colleagues, including Xinhua Shu and Alan Finlay Wright. These partnerships have contributed to the development and success of his innovative therapies.

Conclusion

Basil Pawlyk's contributions to gene therapy for retinitis pigmentosa highlight his dedication to advancing medical science. His innovative methods and collaborations with esteemed institutions and colleagues underscore the importance of teamwork in achieving breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…